MetLife's 401(k) Trust and Investment Accounts Trim $180K in Stock Holdings
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
MetLife has filed a Form 144 notice for the proposed sale of 1,024 shares of common stock with an aggregate market value of $81,879.04. The sale is planned to be executed through Goldman Sachs on the NYSE, with an approximate sale date of June 27, 2025.
The securities to be sold were acquired in three separate purchases during 2013:
- 31 shares from Deutsche Bank on January 31, 2013
- 902 shares from Goldman Sachs on March 13, 2013
- 91 shares from Goldman Sachs on May 15, 2013
Recent trading activity shows that related entities have sold 1,256 shares in the past three months, totaling approximately $99,076.70 in gross proceeds. The filing was made by the MetLife 401(k) Plan Trust, which maintains an affiliate discretionary manager relationship with the issuer. The company has 671,297,826 shares outstanding.
Positive
- None.
Negative
- None.
FAQ
What recent MET stock sales were disclosed in the three months prior to this Form 144?
In the three months prior to this filing, there were several sales of MET stock: 221 shares by Separate Account II on 6/13/2025, and on 6/20/2025: 547 shares by MetLife 401k Plan Trust, 360 shares by Separate Account SPI, 101 shares by Separate Account II, and 27 shares by Separate Account 149, totaling 1,256 shares.